CSF biomarking for diagnosis and treatment assessment in neurodegeneration

Authors


Address correspondence and reprint requests to John Hardy, Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, London, WC1N 3BG, UK. E-mail: j.hardy@ucl.ac.uk

No abstract is available for this article.

Ancillary